Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 7/1/21 → 1/29/26 |
Funding
- Syneos Health LLC: $76,380.00
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Proliferative Lupus Nephritis or Immunoglobulin A Nephropathy
- Ahmed, Sadiq (PI)